InsidersTradesSigma
Track the 通化东宝 share price and the full directors' dealings record of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 通化东宝 has published 2 reports. Market capitalisation: €16.4bn. The latest transaction was filed on 13 November 2024 (Purchase). Among the most active insiders: 王君业. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Tonghua Dongbao is a company in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research, development, and production of medications, particularly for diabetes treatment.